Jasiak-Zatońska et al. [59] using a commercially available ELISA kit (Human AQP1 ELISA Kit, MBS262447, MyBiosource Inc., Eersel, Netherlands) claimed that patients with MS diagnosis had higher AQP1-Ab levels than those with NMOSD phenotype. This evidence concerns the gene AQP1 and myeloid sarcoma.